{
    "id": "dbpedia_5544_0",
    "rank": 55,
    "data": {
        "url": "https://www.urmc.rochester.edu/people/112363496-john-t-horan",
        "read_more_link": "",
        "language": "en",
        "title": "John T. Horan, M.D., M.P.H.",
        "top_image": "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/3998.jpg",
        "meta_img": "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/3998.jpg",
        "images": [
            "https://www.urmc.rochester.edu/getmedia/2d3c0d22-0eae-4ef9-b5cd-2051e0747bd8/UR-Medicine-logo-svg.svg?maxsidesize=400&resizemode=force",
            "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/3998.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The University of Rochester Medical Center (URMC) is one of the nation’s leading academic medical centers. It forms the centerpiece of the University of Rochester’s health research, teaching and patient care missions.\r\n\r\nThe University of Rochester Medical Center is a private, coeducational, nonsectarian, and nonprofit research university.",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "University of Rochester Medical Center",
        "canonical_link": "https://www.urmc.rochester.edu/people/112363496-john-t-horan",
        "text": "Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.\n\nTakahashi T, Al-Kofahi M, Jaber M, Bratrude B, Betz KM, Suessmuth Y, Yu A, Neuberg DS, Choi SW, Davis JH, Duncan C, Giller RH, Grimley M, Harris AC, Jacobsohn DA, Lalefar NR, Farhadfar N, Pulsipher MA, Shenoy S, Petrovic A, Schultz KR, Yanik GA, Blazar BR, Horan JT, Watkins B, Langston A, Qayed M, Kean LS\n\nBlood.. 2023 August 24142 (8):700-710. Epub 1900 01 01.\n\nAbatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.\n\nRaghunandan S, Gorfinkel L, Graiser M, Bratrude B, Suessmuth Y, Gillespie S, Westbrook AL, Williams KM, Schoettler ML, Kean LS, Horan JT, Langston AA, Qayed M, Watkins B\n\nBlood advances.. 2023 August 227 (16):4395-4399. Epub 1900 01 01.\n\nAbatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.\n\nStenger EO, Watkins B, Rogowski K, Chiang KY, Haight A, Leung K, Qayed M, Raghunandan S, Suessmuth Y, Kean L, Horan J\n\nBlood advances.. 2023 May 237 (10):2196-2205. Epub 1900 01 01.\n\nLong-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.\n\nStenger E, Xiang Y, Wetzel M, Gillespie S, Chellapandian D, Shah R, Arnold SD, Bhatia M, Chaudhury S, Eckrich MJ, Kanter J, Kasow KA, Krajewski J, Nickel RS, Ngwube AI, Olson TS, Rangarajan HG, Wobma H, Guilcher GMT, Horan JT, Krishnamurti L, Shenoy S, Abraham A\n\nTransplantation and cellular therapy.. 2023 January 29 (1):47.e1-47.e10. Epub 10/20/2022.\n\nHematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.\n\nTarlock K, Sulis ML, Chewning JH, Pollard JA, Cooper T, Gamis A, Shenoy S, Kutny M, Horan J, Meshinchi S, Boelens JJ, Bleakley M, Carpenter PA, Kolb EA\n\nTransplantation and cellular therapy.. 2022 September 28 (9):530-545. Epub 06/16/2022.\n\nAbatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.\n\nQayed M, Watkins B, Gillespie S, Bratrude B, Betz K, Choi SW, Davis J, Duncan C, Giller R, Grimley M, Harris AC, Jacobsohn D, Lalefar N, Norkin M, Farhadfar N, Pulsipher MA, Shenoy S, Petrovic A, Schultz KR, Yanik GA, Waller EK, Langston A, Kean LS, Horan JT\n\nBlood advances.. 2022 February 86 (3):746-749. Epub 1900 01 01.\n\nPhase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.\n\nWatkins B, Qayed M, McCracken C, Bratrude B, Betz K, Suessmuth Y, Yu A, Sinclair S, Furlan S, Bosinger S, Tkachev V, Rhodes J, Tumlin AG, Narayan A, Cribbin K, Gillespie S, Gooley TA, Pasquini MC, Hebert K, Kapoor U, Rogatko A, Tighiouart M, Kim S, Bresee C, Choi SW, Davis J, Duncan C, Giller R, Grimley M, Harris AC, Jacobsohn D, Lalefar N, Norkin M, Farhadfar N, Pulsipher MA, Shenoy S, Petrovic A, Schultz KR, Yanik GA, Waller EK, Levine JE, Ferrara JL, Blazar BR, Langston A, Horan JT, Kean LS\n\nJournal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2021 June 1039 (17):1865-1877. Epub 01/15/2021.\n\nHematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.\n\nMeier ER, Abraham AA, Ngwube A, Janson IA, Guilcher GMT, Horan J, Kasow KA\n\nPediatric blood & cancer.. 2021 March 68 (3):e28861. Epub 01/06/2021.\n\nSpatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8 T cells drive gastrointestinal acute graft-versus-host disease.\n\nTkachev V, Kaminski J, Potter EL, Furlan SN, Yu A, Hunt DJ, McGuckin C, Zheng H, Colonna L, Gerdemann U, Carlson J, Hoffman M, Olvera J, English C, Baldessari A, Panoskaltsis-Mortari A, Watkins B, Qayed M, Suessmuth Y, Betz K, Bratrude B, Langston A, Horan JT, Ordovas-Montanes J, Shalek AK, Blazar BR, Roederer M, Kean LS\n\nScience translational medicine.. 2021 January 1313 (576)Epub 1900 01 01.\n\nHuman leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.\n\nNickel RS, Horan JT, Abraham A, Qayed M, Haight A, Ngwube A, Liang H, Luban NLC, Hendrickson JE\n\nBritish journal of haematology.. 2020 April 189 (1):162-170. Epub 11/01/2019.\n\nMixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.\n\nOrgel E, Alexander TB, Wood BL, Kahwash SB, Devidas M, Dai Y, Alonzo TA, Mullighan CG, Inaba H, Hunger SP, Raetz EA, Gamis AS, Rabin KR, Carroll AJ, Heerema NA, Berman JN, Woods WG, Loh ML, Zweidler-McKay PA, Horan JT,\n\nCancer.. 2020 February 1126 (3):593-601. Epub 10/29/2019.\n\nDonor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders.\n\nWoolfrey A, Wang T, Lee SJ, Haagenson MD, Chen G, Fleischhauer K, Horan J, Hsu K, Verneris M, Spellman SR, Fernandez-Vina M\n\nBone marrow transplantation.. 2019 March 54 (3):494-496. Epub 09/19/2018.\n\nThe genetic basis and cell of origin of mixed phenotype acute leukaemia.\n\nAlexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, Payne-Turner D, Yoshihara H, Loh ML, Horan J, Buldini B, Basso G, Elitzur S, de Haas V, Zwaan CM, Yeoh A, Reinhardt D, Tomizawa D, Kiyokawa N, Lammens T, De Moerloose B, Catchpoole D, Hori H, Moorman A, Moore AS, Hrusak O, Meshinchi S, Orgel E, Devidas M, Borowitz M, Wood B, Heerema NA, Carrol A, Yang YL, Smith MA, Davidsen TM, Hermida LC, Gesuwan P, Marra MA, Ma Y, Mungall AJ, Moore RA, Jones SJM, Valentine M, Janke LJ, Rubnitz JE, Pui CH, Ding L, Liu Y, Zhang J, Nichols KE, Downing JR, Cao X, Shi L, Pounds S, Newman S, Pei D, Guidry Auvil JM, Gerhard DS, Hunger SP, Inaba H, Mullighan CG\n\nNature.. 2018 October 562 (7727):373-379. Epub 09/12/2018.\n\nTreatment strategies for adolescent and young adult patients with acute myeloid leukemia.\n\nO'Dwyer K, Freyer DR, Horan JT\n\nBlood.. 2018 July 26132 (4):362-368. Epub 06/12/2018.\n\nInfluence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.\n\nQayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2018 March 24 (3):521-528. Epub 11/16/2017.\n\nIsolated myeloperoxidase expression in pediatric B/myeloid mixed phenotype acute leukemia is linked with better survival.\n\nRaikar SS, Park SI, Leong T, Jaye DL, Keller FG, Horan JT, Woods WG\n\nBlood.. 2018 February 1131 (5):573-577. Epub 12/09/2017.\n\nEarly blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents.\n\nSano H, Hilinski JA, Qayed M, Applegate K, Newton JG, Watkins B, Chiang KY, Horan J\n\nPediatric blood & cancer.. 2018 February 65 (2)Epub 09/17/2017.\n\nCD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia.\n\nNewton JG, Horan JT, Newman S, Rossi MR, Ketterling RP, Park SI\n\nPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.. 2017 June 20 (3):224-231. Epub 02/08/2017.\n\nRecipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant.\n\nWatkins BK, Horan J, Storer B, Martin PJ, Carpenter PA, Flowers ME\n\nBone marrow transplantation.. 2017 April 52 (4):625-626. Epub 12/19/2016.\n\nAfrican American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation.\n\nSano H, Hilinski JA, Applegate K, Chiang KY, Haight A, Qayed M, Horan J\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2017 February 23 (2):357-360. Epub 11/10/2016.\n\nLeukoreduced red blood cell transfusions do not induce platelet glycoprotein antibodies in patients with sickle cell disease.\n\nNickel RS, Winkler AM, Horan JT, Hendrickson JE\n\nTransfusion.. 2016 September 56 (9):2267-73. Epub 07/06/2016.\n\nHaematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.\n\nArnold SD, Bhatia M, Horan J, Krishnamurti L\n\nBritish journal of haematology.. 2016 August 174 (4):515-25. Epub 06/02/2016.\n\nImproved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.\n\nNickel RS, Seashore E, Lane PA, Alazraki AL, Horan JT, Bhatia M, Haight AE\n\nPediatric blood & cancer.. 2016 May 63 (5):908-13. Epub 01/12/2016.\n\nImmunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.\n\nNickel RS, Horan JT, Fasano RM, Meyer E, Josephson CD, Winkler AM, Yee ME, Kean LS, Hendrickson JE\n\nAmerican journal of hematology.. 2015 December 90 (12):1135-41. Epub 10/06/2015.\n\nUse of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.\n\nStenger EO, Chiang KY, Haight A, Qayed M, Kean L, Horan J\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2015 October 21 (10):1845-52. Epub 06/19/2015.\n\nRed blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.\n\nNickel RS, Hendrickson JE, Yee MM, Bray RA, Gebel HM, Kean LS, Miklos DB, Horan JT\n\nBritish journal of haematology.. 2015 July 170 (2):247-56. Epub 04/19/2015.\n\nCMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR? repertoire.\n\nSuessmuth Y, Mukherjee R, Watkins B, Koura DT, Finstermeier K, Desmarais C, Stempora L, Horan JT, Langston A, Qayed M, Khoury HJ, Grizzle A, Cheeseman JA, Conger JA, Robertson J, Garrett A, Kirk AD, Waller EK, Blazar BR, Mehta AK, Robins HS, Kean LS\n\nBlood.. 2015 June 18125 (25):3835-50. Epub 04/07/2015.\n\nUsing fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trial.\n\nHoran JT, Haight A, Dioguardi JL, Brown C, Grizzle A, Shelman C, Kanter J, Hale G, Nieder M, Benton M, Kasow KA, Abraham A, Chiang KY\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2015 May 21 (5):900-5. Epub 01/21/2015.\n\nImmune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.\n\nNickel RS, Osunkwo I, Garrett A, Robertson J, Archer DR, Promislow DE, Horan JT, Hendrickson JE, Kean LS\n\nBritish journal of haematology.. 2015 May 169 (4):574-83. Epub 03/05/2015.\n\nRisk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation.\n\nQayed M, Khurana M, Hilinski J, Gillespie S, McCracken C, Applegate K, Chiang KY, Horan J\n\nPediatric blood & cancer.. 2015 February 62 (2):364-366. Epub 09/27/2014.\n\nThe Role of Intestinal Microbiota in Graft versus Host Disease.\n\nQayed M, Horan JT\n\nMini reviews in medicinal chemistry.. 2015 16 (3):193-9. Epub 1900 01 01.\n\nRelative defects in mucosal immunity predict acute graft-versus-host disease.\n\nAugust KJ, Chiang KY, Qayed M, Dulson A, Worthington-White D, Cole CR, Horan JT\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2014 July 20 (7):1056-9. Epub 03/15/2014.\n\nOutcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.\n\nHitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA,\n\nPediatric blood & cancer.. 2014 June 61 (6):1126-8. Epub 01/04/2014.\n\nTransplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.\n\nBitan M, He W, Zhang MJ, Abdel-Azim H, Ayas MF, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, Horan JT, Jodele S, Kitko CL, Schultz KR, Kletzel M, Kasow KA, Lehmann LE, Mehta PA, Shah N, Pulsipher MA, Prestidge T, Seber A, Shenoy S, Woolfrey AE, Yu LC, Davies SM\n\nBlood.. 2014 March 6123 (10):1615-20. Epub 01/16/2014.\n\nComparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation.\n\nKelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG\n\nPediatric blood & cancer.. 2014 February 61 (2):269-75. Epub 08/19/2013.\n\nEffect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.\n\nEckrich MJ, Ahn KW, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M\n\nAmerican journal of hematology.. 2014 February 89 (2):125-9. Epub 11/15/2013.\n\nDifferences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.\n\nCanner J, Alonzo TA, Franklin J, Freyer DR, Gamis A, Gerbing RB, Lange BJ, Meshinchi S, Woods WG, Perentesis J, Horan J\n\nCancer.. 2013 December 1119 (23):4162-9. Epub 09/19/2013.\n\nOutcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.\n\nWoods WG, Franklin AR, Alonzo TA, Gerbing RB, Donohue KA, Othus M, Horan J, Appelbaum FR, Estey EH, Bloomfield CD, Larson RA\n\nCancer.. 2013 December 1119 (23):4170-9. Epub 09/19/2013.\n\nIn vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.\n\nKoura DT, Horan JT, Langston AA, Qayed M, Mehta A, Khoury HJ, Harvey RD, Suessmuth Y, Couture C, Carr J, Grizzle A, Johnson HR, Cheeseman JA, Conger JA, Robertson J, Stempora L, Johnson BE, Garrett A, Kirk AD, Larsen CP, Waller EK, Kean LS\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2013 November 19 (11):1638-49. Epub 09/15/2013.\n\nThe impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.\n\nHurley CK, Woolfrey A, Wang T, Haagenson M, Umejiego J, Aljurf M, Askar M, Battiwalla M, Dehn J, Horan J, Oudshoorn M, Pidala J, Saber W, Turner V, Lee SJ, Spellman SR\n\nBlood.. 2013 June 6121 (23):4800-6. Epub 05/01/2013.\n\nOutcome of transplantation for acute myelogenous leukemia in children with Down syndrome.\n\nHitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA,\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2013 June 19 (6):893-7. Epub 03/01/2013.\n\nRifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation.\n\nQayed M, Langston A, Chiang KY, August K, Hilinski JA, Cole CR, Rogatko A, Bostick RM, Horan JT\n\nJournal of pediatric hematology/oncology.. 2013 May 35 (4):e149-52. Epub 1900 01 01.\n\nEvaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.\n\nHoran J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, Frangoul H, Gupta V, Hale GA, Hurley CK, Marino S, Oudshoorn M, Reddy V, Shaw P, Lee SJ, Woolfrey A\n\nBlood.. 2012 October 4120 (14):2918-24. Epub 07/24/2012.\n\nHLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.\n\nWoolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, Gajewski J, Hale GA, Horan J, Battiwalla M, Marino SR, Setterholm M, Ringden O, Hurley C, Flomenberg N, Anasetti C, Fernandez-Vina M, Lee SJ\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2011 June 17 (6):885-92. Epub 09/24/2010.\n\nBiomarkers of immune activation to screen for severe, acute GVHD.\n\nAugust KJ, Chiang KY, Bostick RM, Flanders WD, Waller EK, Langston A, Worthington-White D, Rowland P, Moore KF, Khoury HJ, Horan JT\n\nBone marrow transplantation.. 2011 April 46 (4):601-4. Epub 07/12/2010.\n\nReducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?\n\nHoran JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC\n\nJournal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2011 March 129 (7):805-13. Epub 01/10/2011.\n\nHLA-matched sibling bone marrow transplantation for ?-thalassemia major.\n\nSabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC\n\nBlood.. 2011 February 3117 (5):1745-50. Epub 11/30/2010.\n\nSafety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease.\n\nMcPherson ME, Hutcherson D, Olson E, Haight AE, Horan J, Chiang KY\n\nBone marrow transplantation.. 2011 January 46 (1):27-33. Epub 03/22/2010.\n\nGVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression.\n\nMiller WP, Srinivasan S, Panoskaltsis-Mortari A, Singh K, Sen S, Hamby K, Deane T, Stempora L, Beus J, Turner A, Wheeler C, Anderson DC, Sharma P, Garcia A, Strobert E, Elder E, Crocker I, Crenshaw T, Penedo MC, Ward T, Song M, Horan J, Larsen CP, Blazar BR, Kean LS\n\nBlood.. 2010 December 9116 (24):5403-18. Epub 09/10/2010.\n\nOutcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.\n\nShaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, Burke M, Cairo MS, Chen AR, Davies SM, Frangoul H, Gajewski J, Gale RP, Godder K, Hale GA, Heemskerk MB, Horan J, Kamani N, Kasow KA, Chan KW, Lee SJ, Leung WH, Lewis VA, Miklos D, Oudshoorn M, Petersdorf EW, Ringdén O, Sanders J, Schultz KR, Seber A, Setterholm M, Wall DA, Yu L, Pulsipher MA\n\nBlood.. 2010 November 11116 (19):4007-15. Epub 07/29/2010.\n\nLeukocyte adhesion deficiency-III in an African-American patient.\n\nSabnis H, Kirpalani A, Horan J, McDowall A, Svensson L, Cooley A, Merck T, Jobe S, Hogg N, Briones M\n\nPediatric blood & cancer.. 2010 July 1555 (1):180-2. Epub 1900 01 01.\n\nIs the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?\n\nQayed M, Thompson A, Applegate K, Haight A, Rogatko A, Chiang KY, Horan J\n\nPediatric blood & cancer.. 2010 July 1555 (1):199-201. Epub 1900 01 01.\n\nPulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.\n\nWalters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, Buchanan GR, Bunin N, Dickerhoff R, Giller R, Haut PR, Horan J, Hsu LL, Kamani N, Levine JE, Margolis D, Ohene-Frempong K, Patience M, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sullivan KM,\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2010 February 16 (2):263-72. Epub 10/12/2009.\n\nRisk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.\n\nHoran JT, Carreras J, Tarima S, Camitta BM, Gale RP, Hale GA, Hinterberger W, Marsh J, Passweg JR, Walters MC, Eapen M\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2009 May 15 (5):626-31. Epub 1900 01 01.\n\nClinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow.\n\nChiang KY, Haight A, Horan J, Olson E, Gartner A, Hartman D, Youssef S, Worthington-White D\n\nPediatric transplantation.. 2007 May 11 (3):279-85. Epub 1900 01 01.\n\nEffect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.\n\nEggleston B, Patience M, Edwards S, Adamkiewicz T, Buchanan GR, Davies SC, Dickerhoff R, Donfield S, Feig SA, Giller RH, Haight A, Horan J, Hsu LL, Kamani N, Lane P, Levine JE, Margolis D, Moore TB, Ohene-Frempong K, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sleight B, Thompson AA, Sullivan KM, Walters MC,\n\nBritish journal of haematology.. 2007 February 136 (4):673-6. Epub 1900 01 01.\n\nProphylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials.\n\nWittman B, Horan J, Lyman GH\n\nCancer treatment reviews.. 2006 June 32 (4):289-303. Epub 05/05/2006.\n\nA comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.\n\nMarks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, Trigg ME, Zhang MJ, Horowitz MM\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2006 April 12 (4):438-53. Epub 1900 01 01.\n\nImmunization to minor histocompatibility antigens on transfused RBCs through crosspriming into recipient MHC class I pathways.\n\nZimring JC, Hair GA, Deshpande SS, Horan JT\n\nBlood.. 2006 January 1107 (1):187-9. Epub 08/25/2005.\n\nBusulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.\n\nWall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J,\n\nBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2005 August 11 (8):637-46. Epub 1900 01 01.\n\nHematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.\n\nHoran JT, Liesveld JL, Fenton P, Blumberg N, Walters MC\n\nBone marrow transplantation.. 2005 January 35 (2):171-7. Epub 1900 01 01.\n\nA 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate.\n\nWittman B, Horan J, Baxter J, Goldberg J, Felgar R, Baylor E, Cromwell B, Cross N, Bennett JM\n\nLeukemia research.. 2004 May 28 Suppl 1 :S65-9. Epub 1900 01 01.\n\nSurvival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials.\n\nHoran JT, Liesveld JL, Fernandez ID, Lyman GH, Phillips GL, Lerner NB, Fisher SG\n\nBone marrow transplantation.. 2003 August 32 (3):293-8. Epub 1900 01 01.\n\nFibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.\n\nHoran JT, Francis CW\n\nSeminars in thrombosis and hemostasis.. 2001 December 27 (6):657-66. Epub 1900 01 01.\n\nProthrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections.\n\nHoran JT, Francis CW, Falsey AR, Kolassa J, Smith BH, Hall WJ\n\nThrombosis and haemostasis.. 2001 February 85 (2):245-9. Epub 1900 01 01.\n\nAllogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.\n\nDuerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF\n\nBone marrow transplantation.. 2000 March 25 (5):489-94. Epub 1900 01 01."
    }
}